Track topics on Twitter Track topics that are important to you
Despite some caveats about the SWITCH 1 and SWITCH 2 trials, "any basal insulin associated with a reduced rate of hypoglycemia would seem to represent an advance in therapy," say two editorialists.
Medscape Medical News
Original Article: Could SWITCHing to Insulin Degludec Thwart Hypoglycemia?NEXT ARTICLE
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...